Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED大健康國際集團控股有限公司
(incorporated in the Cayman Islands with limited liability)
(Stock Code: 2211) INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2016 INTERIM RESULTS HIGHLIGHTS Six months ended 30 June 2016 2015RMB Million (Unaudited) | RMB Million (Unaudited) | Change (%) | |
Revenue | 1,903.8 | 2,570.9 | -25.9 |
Gross profit | 519.8 | 736.1 | -29.4 |
Operating profit | 115.3 | 331.0 | -65.2 |
Profit for the period | 87.4 | 248.4 | -64.8 |
EBITDA | 138.1 | 354.2 | -61.0 |
Basic earnings per share - RMB cents | 4.12 | 12.34 | -66.6 |
Gross margin (%) | 27.3 | 28.6 | -1.3pp |
Operating margin (%) | 6.1 | 12.9 | -6.8pp |
Net margin (%) | 4.6 | 9.7 | -5.1pp |
The board of directors (the "Board") of Universal Health International Group Holding Limited (the "Company") is pleased to announce the unaudited interim results of the Company and its subsidiaries (collectively, the "Group") for the six months ended 30 June 2016 (the "Period") together with the comparative figures for the corresponding period in 2015 as follows:
CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (Unaudited) Six months ended 30 JuneNote | 2016 RMB'000 | 2015 RMB'000 | |
Revenue | 2 | 1,903,845 | 2,570,945 |
Cost of sales | 3 | (1,384,006) | (1,834,871) |
Gross profit | 519,839 | 736,074 | |
Selling and marketing expenses | 3 | (360,367) | (358,813) |
Administrative expenses | 3 | (45,374) | (46,628) |
Other income | 1,668 | 414 | |
Other losses - net | (417) | (10) | |
Operating profit | 115,349 | 331,037 | |
Finance income | 4 | 7,192 | 4,523 |
Finance costs | 4 | (2,721) | (4,632) |
Finance income/(costs) - net | 4 | 4,471 | (109) |
Share of post-tax profits of joint ventures | 441 | 545 | |
Share of loss of an associate | (59) | - | |
Profit before income tax | 120,202 | 331,473 | |
Income tax expenses | 5 | (32,803) | (83,098) |
Profit for the period | 87,399 | 248,375 | |
Profit attributable to: - Owners of the Company | 85,837 | 244,678 | |
- Non-controlling interests | 1,562 | 3,697 |
87,399 | 248,375 | ||
Earnings per share attributable to owners of the Company for the period (RMB cents) - Basic and diluted | 6 | 4.12 | 12.34 |
Other comprehensive loss Item that may be reclassified to profit or loss Currency translation differences | (2,249) | - | |
Total comprehensive income for the period | 85,150 | 248,375 | |
Total comprehensive income attributable to: - Owners of the Company | 83,588 | 244,678 | |
- Non-controlling interests | 1,562 | 3,697 | |
85,150 | 248,375 |
Note | (Unaudited) As at 30 June 2016 RMB'000 | (Audited) As at 31 December 2015 RMB'000 | |
ASSETS Non-current assets Property, plant and equipment | 109,436 | 103,167 | |
Land use rights | 3,666 | 3,713 | |
Intangible assets | 662,119 | 672,055 | |
Investments in joint ventures | 7,961 | 7,520 | |
Investments in an associate | 243,017 | - | |
Deferred income tax assets | 14,042 | 19,297 | |
Total non-current assets | 1,040,241 | 805,752 | |
Current assets Trade and other receivables | 8 | 354,845 | 442,853 |
Inventories | 371,745 | 398,605 | |
Restricted cash | 207,228 | 227,414 | |
Cash and cash equivalents | 1,515,961 | 1,333,320 | |
Total current assets | 2,449,779 | 2,402,192 | |
Total assets | 3,490,020 | 3,207,944 | |
EQUITY Equity attributable to owners of the Company Share capital | 14,878 | 12,259 | |
Other reserves | 1,530,589 | 1,319,669 | |
Retained earnings | 1,342,559 | 1,256,722 | |
2,888,026 | 2,588,650 | ||
Non-controlling interests | 31,282 | 29,720 | |
Total equity | 2,919,308 | 2,618,370 |
As at 31 December
LIABILITIES Non-current liabilities 2016 2015Note RMB'000 RMB'000
Deferred income tax liabilities 43,940 46,585
Current liabilitiesBorrowings | 173,330 | 166,920 | |
Trade and other payables | 9 | 349,424 | 373,464 |
Current income tax liabilities | 4,018 | 2,605 | |
Total current liabilities | 526,772 | 542,989 | |
Total liabilities | 570,712 | 589,574 | |
Total equity and liabilities | 3,490,020 | 3,207,944 |
Jintian Pharmaceutical Group Ltd. published this content on 25 August 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 25 August 2016 05:44:08 UTC.
Original documenthttp://www.jtyyjt.com/d/file/touzizheguanxi/gonggaojigonghan/2016/2016-08-25/d3ec50053e6b932285380929a63763fd.pdf
Public permalinkhttp://www.publicnow.com/view/A4AB755C5ACF42743FAD86EA8EA7B251AEA825DC